natgillin/translations-raw huggingface dataset:
Lipegfilgrastim acts in the same way as naturally produced G‑CSF, increasing the production of neutrophils and thereby helping to reduce the duration of neutropenia and to prevent febrile neutropenia (a sign of infection) in patients undergoing chemotherapy.
Lipegfilgrastim djeluje na isti način kao i prirodno proizvedeni G-CSF, povećavajući proizvodnju neutrofila i time pomaže u skraćivanju trajanja neutropenije te sprječavanju febrilne neutropenije (znak infekcije) kod bolesnika koji primaju kemoterapiju.
Lipegfilgrastim and filgrastim induced a marked increase in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes and/or lymphocytes.
Lipegfilgrastim i filgrastim su izazvali izrazito povećanje broja neutrofila u perifernoj krvi unutar 24 sata, uz manja povećanja broja monocita i/ili limfocita.
Lipegfilgrastim is a covalent conjugate of filgrastim with a single methoxy polyethylene glycol (PEG) molecule via a carbohydrate linker consisting of glycine, N-acetylneuraminic acid and
Lipegfilgrastim je kovalentni konjugat filgrastima i jedne molekule metoksipolietilenglikola (PEG) putem ugljikohidratnog povezivača koji se sastoji od glicina, N-acetilneuraminske kiseline i
Lipegfilgrastim is similar to filgrastim, which has been available in the European Union (EU) for a number of years.
Lipegfilgrastim je sličan filgrastimu, koji je već više godina dostupan u Europskoj uniji (EU).
Lipid alterations
Napadaji
Lipid alterations
Time se
Lipid disorders should be managed as clinically appropriate.
Poremećaje lipida potrebno je liječiti kako je klinički opravdano.
LIPID LOWERING AGENTS
HIPOLIPEMICI
LIPID LOWERING AGENTS
LIJEKOVI ZA SNIŽAVANJE LIPIDA
Lipid Lowering Drugs
Hipolipemici
LIPID LOWERING MEDICINAL PRODUCTS
HIPOLIPEMICI
LIPID LOWERING MEDICINAL PRODUCTS
LIJEKOVI ZA SMANJENJE LIPIDA
LIPID LOWERING MEDICINAL PRODUCTS
Razine kolesterola moraju se
Lipid parameters
Vrijednosti lipida
Lipid profiles should be determined prior to initiating Tasigna therapy, assessed at month 3 and 6 after initiating therapy and at least yearly during chronic therapy.
Potrebno je odrediti profil lipida prije početka liječenja Tasignom, procijeniti ga u 3. i 6. mjesecu nakon početka terapije te najmanje jedanput godišnje tijekom kronične terapije.
lipid-lowering
nižavanje lipida
Lipid-lowering agents
Lijekovi za snižavanje razine lipida
LIPID-LOWERING MEDICINAL PRODUCTS
HIPOLIPEMICI
lipids increased
povišena razina lipida
Lipids, Change from baseline
Lipidi, promjena u odnosu na početne vrijednosti
Lipids: hyperlipidaemia has been identified as an effect associated with the use of bexarotene in clinical studies.
Lipidi: U kliničkim se ispitivanjima prepoznala povezanost između hiperlipidemije i primjene beksarotena.
lipoatrophy
indrom lipoatrofije
lipoatrophy
lipoatrofija
Lipoatrophy was commonly reported in patients treated with stavudine in combination with other antiretrovirals (see section 4.4).
Lipoatrofija je često bila zabilježena u bolesnika liječenih stavudinom u kombinaciji s drugim antiretrovirusnim lijekovima (vidjeti dio 4.4).
Lipoatrophy: on the basis of mitochondrial toxicity stavudine has been shown to cause loss of subcutaneous fat, which is most evident in the face, limbs and buttocks.
Lipoatrofija: temeljeno na mitohondrijskoj toksičnosti pokazano je da stavudin uzrokuje gubitak subkutane masnoće osobito na licu, udovima i stražnjici.
Lipodystrophy
lipodistrofija
Lipodystrophy (thickening or pitting of the skin) is uncommon ( 1/1,000 to <1/100).
Lipodistrofija (zadebljanja ili ulegnuća na koži) je manje česta (≥ 1/1000 i < 1/100).
Lipodystrophy acquired
stečena lipodistrofija
Lipodystrophy at the injection site is uncommon (1/1,000 to <1/100).
Lipodistrofija na mjestu injekcije je manje česta nuspojava (1/1000 i < 1/100).
Lipodystrophy at the injection site is uncommon.
Lipodistrofija na mjestu injekcije je manje česta nuspojava.
Lipohyper- trophy
lipohipertrofija
Lipohypertro-
lipohipertrofija
Lipohypertro- phy
lipohipertrofija
Lipohypertrophy
lipohipertrofija
lipolytic activity: 5,000 units*
lipolitička aktivnost: 5000 jedinica
lipolytic activity: amylolytic activity:
amilolitička aktivnost:
Lipoma
lipom
Lipoprotein lipase is a key ‘first step’ enzyme in the metabolism of lipoproteins following fat intake with diet.
Lipoproteinska lipaza je ključni enzim „prvog koraka“ u metabolizmu lipoproteina nakon unosa masnoća s prehranom.
Liposarcoma
Liposarkom
Liposomal-encapsulated compared with conventional doxorubicin was not found more active in doxorubicin resistant cell lines in vitro.
Nije nađeno da je liposomima enkapsulirani doksorubicin aktivniji od standardnog doksorubicina u linijama stanica koje su bile otporne na doksorubicin in vitro.
Liposome–encapsulated doxorubicin corresponding to 50 mg doxorubicin hydrochloride
Doksorubicin enkapsuliran u liposome koji odgovara 50 mg doksorubicinklorida.
Liposome–encapsulated doxorubicin–citrate complex corresponding to 50 mg doxorubicin hydrochloride (HCl).
Kompleks doksorubicin-citrat inkapsuliran u liposome koji odgovara 50 mg doksorubicinklorida (HCl).
Liprolog
Humalog
Liprolog 100 units/ml KwikPen and Liprolog 200 units/ml KwikPen
Liprolog 100 jedinica/ml KwikPen i Liprolog 200 jedinica/ml KwikPen
Liprolog 100 units/ml solution for injection in cartridge insulin lispro
Liprolog 100 jedinica/ml otopina za injekciju u ulošku inzulin lispro
Liprolog 100 units/ml solution for injection in cartridge Insulin lispro (rDNA origin)
Liprolog 100 jedinica/ml otopina za injekciju u ulošku inzulin lispro (dobiven tehnologijom rekombinantne DNK)
Liprolog 100 units/ml solution for injection in vial Insulin lispro
Liprolog 100 jedinica/ml otopina za injekciju u bočici inzulin lispro
Liprolog 100 units/ml solution for injection in vial Insulin lispro (rDNA origin)
Liprolog 100 jedinica/ml otopina za injekciju u bočici inzulin lispro (dobiven tehnologijom rekombinantne DNK)
Liprolog 100 units/ml, solution for injection in cartridge
Liprolog 100 jedinica/ml otopina za injekciju u ulošku
Liprolog 100 units/ml, solution for injection in cartridge is made by:
Liprolog 100 jedinica/ml otopinu za injekciju u ulošku proizvodi:
Liprolog 100 units/ml, solution for injection in vial
Liprolog 100 jedinica/ml otopina za injekciju u bočici
Liprolog 100 units/ml, solution for injection in vial is made by:
Liprolog 100 jedinica/ml otopinu za injekciju u bočici proizvodi:
Liprolog 100 units/ml, solution for injection is a sterile, clear, colourless, aqueous solution and contains 100 units of insulin lispro in each millilitre (100 units/ml) solution for injection.
Liprolog 100 jedinica/ml otopina za injekciju je sterilna, bistra, bezbojna vodena otopina koja sadrži 100 jedinica inzulina lispro u jednom mililitru (100 jedinica/ml) otopine za injekciju.
Liprolog 200 units/ml
Liprolog 200 jedinica/ml
Liprolog 200 units/ml KwikPen (“Pen”) is a disposable pre-filled pen containing 3 ml (600 units, 200 units/ml) of insulin lispro solution for injection.
Liprolog 200 jedinica/ml KwikPen (“Pen”) je napunjena brizgalica za jednokratnu uporabu koja sadrži 3 ml (600 jedinica, 200 jedinica/ml) otopine inzulina lispro za injekciju.
Liprolog 200 units/ml KwikPen is for patients taking more than 20 units of rapid-acting insulin a day.
Liprolog 200 jedinica/ml KwikPen namijenjen je za bolesnike koji dnevno primjenjuju više od 20 jedinica brzodjelujućeg inzulina.
Liprolog 200 units/ml KwikPen, solution for injection Insulin lispro
Liprolog 200 jedinica/ml KwikPen, otopina za injekciju inzulin lispro
Liprolog 200 units/ml KwikPen, solution for injection is a sterile, clear, colourless, aqueous solution and contains 200 units of insulin lispro in each millilitre (200 units/ml) solution for injection.
Liprolog 200 jedinica/ml KwikPen otopina za injekciju je sterilna, bistra, bezbojna vodena otopina koja sadrži 200 jedinica inzulina lispro u jednom mililitru (200 jedinica/ml) otopine za injekciju.
Liprolog 200 units/ml solution for injection in pre-filled pen
Liprolog 200 jedinica/ml otopina za injekciju u napunjenoj brizgalici
Liprolog 200 units/ml solution for injection in pre-filled pen Insulin lispro
Liprolog 200 jedinica/ml otopina za injekciju u napunjenoj brizgalici inzulin lispro
Liprolog 200 units/ml solution for injection is injected under the skin (subcutaneously) of your stomach area, buttocks, upper legs or upper arms.
Liprolog 200 jedinica/ml otopina za injekciju injicira pod kožu (supkutano) na području trbuha, stražnjice, natkoljenice ili nadlaktice.
Liprolog 200 units/ml, solution for injection in pre-filled pen insulin lispro
Liprolog 200 jedinica/ml otopina za injekciju u napunjenoj brizgalici inzulin lispro
Liprolog and Liprolog Mix are normally given shortly before a meal, but they can be given just after a meal if necessary.
Liprolog i Liprolog Mix se normalno primjenjuju neposredno prije obroka, no mogu se primjeniti i neposredno nakon obroka, ukoliko je to potrebno.
Liprolog Basal 100 units/ml KwikPen, suspension for injection
Liprolog Basal 100 jedinica/ml KwikPen, suspenzija za injekciju
Liprolog Basal 100 units/ml KwikPen, suspension for injection insulin lispro
Liprolog Basal 100 jedinica/ml KwikPen suspenzija za injekciju inzulin lispro
Liprolog Basal 100 units/ml KwikPen, suspension for injection Insulin lispro protamine suspension
Liprolog Basal 100 jedinica/ml KwikPen, suspenzija za injekciju suspenzija inzulina lispro s protaminom
Liprolog Basal 100 units/ml KwikPen, suspension for injection Insulin lispro protamine suspension (rDNA origin)
Liprolog Basal 100 jedinica/ml KwikPen, suspenzija za injekciju suspenzija inzulina lispro s protaminom (dobiven tehnologijom rekombinantne DNK)
Liprolog Basal 100 units/ml KwikPen, suspension for injection is a white, sterile suspension and contains 100 units of insulin lispro in each millilitre (100 units/ml) suspension for injection.
Liprolog Basal 100 jedinica/ml KwikPen suspenzija za injekciju je bijela sterilna suspenzija, koja sadrži 100 jedinica inzulina lispro u jednom mililitru (100 jedinica/ml) suspenzije za injekciju.
Liprolog Basal 100 units/ml KwikPen, suspension for injection is made by:
Liprolog Basal 100 jedinica/ml KwikPen suspenziju za injekciju proizvodi:
Liprolog Basal 100 units/ml suspension for injection in cartridge
Liprolog Basal 100 jedinica/ml suspenzija za injekciju u ulošku
Liprolog Basal 100 units/ml suspension for injection in cartridge insulin lispro
Liprolog Basal 100 jedinica/ml suspenzija za injekciju u ulošku inzulin lispro
Liprolog Basal 100 units/ml suspension for injection in cartridge Insulin lispro protamine suspension
Liprolog Basal 100 jedinica/ml suspenzija za injekciju u ulošku suspenzija inzulina lispro s protaminom
Liprolog Basal 100 units/ml suspension for injection in cartridge Insulin lispro protamine suspension (rDNA origin)
Liprolog Basal 100 jedinica/ml suspenzija za injekciju u ulošku suspenzija inzulina lispro s protaminom (dobiven tehnologijom rekombinantne DNK)
Liprolog Basal 100 units/ml suspension for injection in cartridge is made by:
Liprolog Basal 100 jedinica/ml suspenziju za injekciju u ulošku proizvodi:
Liprolog Basal can be mixed with or given in conjunction with Liprolog.
Liprolog Basal može se miješati ili davati zajedno s lijekom Liprolog.
Liprolog Basal cartridges are not designed to allow any other insulin to be mixed in the cartridge .
Liprolog Basal ulošci nisu napravljeni za miješanje drugih inzulina unutar uloška kao niti za ponovno punjenje.
Liprolog Basal cartridges are to be used with a CE marked pen as recommended in the information provided by the device manufacturer.
Ulošci lijeka Liprolog Basal moraju se koristiti s brizgalicama koje imaju oznaku CE, sukladno preporukama proizvođača u uputi za pomagalo.
Liprolog Basal consists of insulin lispro protamine suspension.
Liprolog Basal sastoji se od suspenzije inzulina lispro s protaminom.
Liprolog Basal has a prolonged mode of action compared to soluble insulin
Učinak lijeka Liprolog Basal traje dulje nego učinak topljivog inzulina.
Liprolog Basal has a prolonged mode of action compared to soluble insulin.
Učinak lijeka Liprolog Basal traje dulje nego učinak topljivog inzulina.
Liprolog Basal is a substitute for your own insulin and is used to control glucose in the long term.
Liprolog Basal je zamjena za Vaš vlastiti inzulin i namijenjen je za dugotrajnu kontrolu šećera.
Liprolog Basal is a white, sterile suspension.
Liprolog Basal je bijela sterilna suspenzija.
Liprolog Basal is indicated for the treatment of patients with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
Liprolog Basal indiciran je za liječenje bolesnika sa šećernom bolešću kojima je za održavanje normalne homeostaze glukoze potreban inzulin.
Liprolog Basal is used to treat diabetes.
Liprolog Basal se koristi za liječenje šećerne bolesti.
Liprolog Basal KwikPen is used to treat diabetes.
Liprolog Basal KwikPen se koristi za liječenje šećerne bolesti.
Liprolog Basal should only be given by subcutaneous injection.
Liprolog Basal se smije davati samo supkutanom injekcijom.
Liprolog Basal: insulin lispro protamine suspension;
Liprolog Basal: suspenzija inzulina lispro protamina;
Liprolog can be used in conjunction with a longer-acting insulin or oral sulphonylurea agents, on the advice of a physician.
Liprolog se, prema preporuci liječnika, može primjenjivati zajedno s inzulinom duljeg djelovanja ili peroralnim lijekovima iz skupine sulfonilureja.
Liprolog cartridges are to be used with a CE marked pen as recommended in the information provided by the device manufacturer.
Ulošci lijeka Liprolog moraju se koristiti s brizgalicama koje imaju oznaku CE, sukladno preporukama proizvođača u uputi za pomagalo.
Liprolog is a sterile, clear, colourless, aqueous solution.
Liprolog je sterilna, bistra, bezbojna vodena otopina.
Liprolog is already dissolved in water, so you do not need to mix it.
Liprolog je već otopljen u vodi, tako da ga ne morate miješati.
Liprolog KwikPen 100 units/ml solution for injection insulin lispro
Liprolog KwikPen 100 jedinica/ml otopina za injekciju inzulin lispro
Liprolog KwikPen 100 units/ml solution for injection Insulin lispro
Liprolog KwikPen 100 jedinica/ml, otopina za injekciju inzulin lispro
Liprolog KwikPen 100 units/ml solution for injection Insulin lispro (rDNA origin)
Liprolog KwikPen 100 jedinica/ml, otopina za injekciju inzulin lispro (dobiven tehnologijom rekombinantne DNK)
Liprolog KwikPen 100 units/ml, solution for injection
Liprolog KwikPen 100 jedinica/ml, otopina za injekciju
Liprolog KwikPen 100 units/ml, solution for injection is a sterile, clear, colourless, aqueous solution and contains 100 units of insulin lispro in each millilitre (100 units/ml) solution for injection.
Liprolog KwikPen 100 jedinica/ml otopina za injekciju je sterilna, bistra, bezbojna vodena otopina koja sadrži 100 jedinica inzulina lispro u jednom mililitru (100 jedinica/ml) otopine za injekciju.
Liprolog KwikPen 100 units/ml, solution for injection is made by:
Liprolog KwikPen 100 jedinica/ml otopinu za injekciju proizvodi:
Liprolog KwikPen is a sterile, clear, colourless, aqueous solution.
Liprolog KwikPen je sterilna, bistra, bezbojna vodena otopina.
Liprolog KwikPen is also indicated for the initial stabilisation of diabetes mellitus.
Liprolog KwikPen indiciran je i za početnu stabilizaciju šećerne bolesti.
Liprolog KwikPen takes effect rapidly and has a shorter duration of activity (2 to 5 hours) given subcutaneously as compared with regular insulin.
Nakon supkutane primjene učinak lijeka Liprolog KwikPen nastupa vrlo brzo i traje kraće (2 do 5 sati) u usporedbi s običnim inzulinom.
Liprolog may be used in children, when an advantage is expected compared to soluble insulin, for example, in the timing of the injection in relation to meals.
Liprolog se može primjenjivati u djece kada se očekuje prednost u odnosu na topljivi inzulin, primjerice pri usklađivanju vremena davanja inzulina s obrocima.
Liprolog Mix 25 consists of 25% insulin lispro solution and 75% insulin lispro protamine suspension.
Liprolog Mix25 se sastoji od 25% otopine inzulina lispro i 75% suspenzije inzulina lispro s protaminom.
Liprolog Mix25 100 units/ml KwikPen suspension for injection
Liprolog Mix25 100 jedinica/ml KwikPen, suspenzija za injekciju
Liprolog Mix25 100 units/ml KwikPen suspension for injection 25% insulin lispro and 75% insulin lispro protamine suspension Subcutaneous use
Liprolog Mix25 100 jedinica/ml KwikPen, suspenzija za injekciju 25% inzulin lispro i 75% suspenzija inzulina lispro s protaminom Za potkožnu primjenu.
Liprolog Mix25 100 units/ml KwikPen suspension for injection insulin lispro
Liprolog Mix25 100 jedinica/ml KwikPen suspenzija za injekciju inzulin lispro
Liprolog Mix25 100 units/ml KwikPen, suspension for injection
Liprolog Mix25 100 jedinica/ml KwikPen, suspenzija za injekciju
Liprolog Mix25 100 units/ml KwikPen, suspension for injection is made by:
Liprolog Mix25 100 jedinica/ml KwikPen suspenziju za injekciju proizvodi:
Liprolog Mix25 100 units/ml suspension for injection in cartridge
Liprolog Mix25 100 jedinica/ml suspenzija za injekciju u ulošku
Liprolog Mix25 100 units/ml suspension for injection in cartridge 25% insulin lispro and 75% insulin lispro protamine suspension Subcutaneous use
Liprolog Mix25 100 jedinica/ml suspenzija za injekciju u ulošku 25% inzulin lispro i 75% suspenzija inzulina lispro s protaminom Za potkožnu primjenu.
Liprolog Mix25 100 units/ml suspension for injection in cartridge insulin lispro
Liprolog Mix25 100 jedinica/ml suspenzija za injekciju u ulošku inzulin lispro
Liprolog Mix25 100 units/ml suspension for injection in cartridge is made by:
Liprolog Mix25 100 jedinica/ml suspenziju za injekciju u ulošku proizvodi:
Liprolog Mix25 cartridges are not designed to allow any other insulin to be mixed in the cartridge.
Liprolog Mix25 ulošci nisu napravljeni za miješanje drugih inzulina unutar uloška kao niti za ponovno punjenje.
Liprolog Mix25 cartridges are to be used with a CE marked pen as recommended in the information provided by the device manufacturer.
Ulošci lijeka Liprolog Mix 25 moraju se koristiti s brizgalicama koje imaju oznaku CE, sukladno preporukama proizvođača u uputi za pomagalo.
Liprolog Mix25 consists of 25% insulin lispro solution and 75% insulin lispro protamine suspension.
Liprolog Mix25 se sastoji od 25% otopine inzulina lispro i 75% suspenzije inzulina lispro s protaminom.
Liprolog Mix25 is a premixed suspension consisting of insulin lispro (fast-acting human insulin analogue) and insulin lispro protamine suspension (intermediate acting human insulin analogue).
Liprolog Mix25 je predmiješana suspenzija koja se sastoji od suspenzije inzulina lispro (analoga humanog inzulina brzog djelovanja) i suspenzije inzulina lispro s protaminom (analoga humanog inzulina srednjedugog djelovanja).
Liprolog Mix25 is a white, sterile suspension
Liprolog Mix25 je bijela sterilna suspenzija.
Liprolog Mix25 is a white, sterile suspension.
Liprolog Mix25 je bijela sterilna suspenzija.
Liprolog Mix25 Liprolog Basal
Humalog Mix25 Humalog Basal
Liprolog Mix25 Suspension (cloudy insulin)
Humalog Mix25 Suspenzija (mutan inzulin)
Liprolog Mix25 works very quickly and longer than soluble insulin.
Učinak lijeka Liprolog Mix25 nastupa vrlo brzo i traje dulje nego učinak topljivog inzulina.
Liprolog Mix25: 25% insulin lispro solution and 75% insulin lispro protamine suspension;
Liprolog Mix25: 25% otopina inzulina lispro i 75% suspenzija inzulina lispro protamina;
Liprolog Mix50 100 units/ml KwikPen suspension for injection
Liprolog Mix50 100 jedinica/ml KwikPen, suspenzija za injekciju
Liprolog Mix50 100 units/ml KwikPen suspension for injection 50% insulin lispro and 50% insulin lispro protamine suspension Subcutaneous use
Liprolog Mix50 100 jedinica/ml KwikPen, suspenzija za injekciju 50% inzulin lispro i 50% suspenzija inzulina lispro s protaminom Za potkožnu primjenu.
Liprolog Mix50 100 units/ml KwikPen suspension for injection insulin lispro
Liprolog Mix50 100 jedinica/ml KwikPen suspenzija za injekciju inzulin lispro
Liprolog Mix50 100 units/ml KwikPen, suspension for injection
Liprolog Mix50 100 jedinica/ml KwikPen, suspenzija za injekciju
Liprolog Mix50 100 units/ml KwikPen, suspension for injection is made by:
Liprolog Mix50 100 jedinica/ml KwikPen suspenziju za injekciju proizvodi:
Liprolog Mix50 100 units/ml suspension for injection in cartridge
Liprolog Mix50 100 jedinica/ml suspenzija za injekciju u ulošku
Liprolog Mix50 100 units/ml suspension for injection in cartridge 50% insulin lispro and 50% insulin lispro protamine suspension Subcutaneous use
Liprolog Mix50 100 jedinica/ml suspenzija za injekciju u ulošku 50% inzulin lispro i 50% suspenzija inzulina lispro s protaminom Za potkožnu primjenu.
Liprolog Mix50 100 units/ml suspension for injection in cartridge insulin lispro
Liprolog Mix50 100 jedinica/ml suspenzija za injekciju u ulošku inzulin lispro
Liprolog Mix50 100 units/ml suspension for injection in cartridge is made by:
Liprolog Mix50 100 jedinica/ml suspenziju za injekciju u ulošku proizvodi:
Liprolog Mix50 cartridges are not designed to allow any other insulin to be mixed in the cartridge .
Liprolog Mix50 ulošci nisu napravljeni za miješanje drugih inzulina unutar uloška kao niti za ponovno punjenje.
Liprolog Mix50 cartridges are to be used with a CE marked pen as recommended in the information provided by the device manufacturer.
Ulošci lijeka Liprolog Mix 50 moraju se koristiti s brizgalicama koje imaju oznaku CE, sukladno preporukama proizvođača u uputi za pomagalo.
Liprolog Mix50 consists of 50% insulin lispro solution and 50% insulin lispro protamine suspension.
Liprolog Mix50 se sastoji od 50% otopine inzulina lispro i 50% suspenzije inzulina lispro s protaminom.
Liprolog Mix50 is a premixed suspension consisting of insulin lispro (fast-acting human insulin analogue) and insulin lispro protamine suspension (intermediate acting human insulin analogue).
Liprolog Mix50 je predmiješana suspenzija koja se sastoji od suspenzije inzulina lispro (analoga humanog inzulina brzog djelovanja) i suspenzije inzulina lispro s protaminom (analoga humanog inzulina srednjedugog djelovanja).
Liprolog Mix50 is a white, sterile suspension.
Liprolog Mix50 je bijela sterilna suspenzija.
Liprolog Mix50 works very quickly and longer than soluble insulin.
Učinak lijeka Liprolog Mix50 nastupa vrlo brzo i traje dulje nego učinak topljivog inzulina.
Liprolog Mix50: 50% insulin lispro solution and 50% insulin lispro protamine suspension.
Liprolog Mix50: 50% otopina inzulina lispro i 50% suspenzija inzulina lispro protamina.
Liprolog preparations should be given by subcutaneous injection or by continuous subcutaneous infusion pump (see section 4.2) and may, although not recommended, also be given by intramuscular injection.
Liprolog treba primijeniti supkutanom injekcijom ili kontinuiranom supkutanom infuzijom pomoću infuzijske pumpe (vidjeti dio 4.2), a može se dati i intramuskularnom injekcijom, iako se to ne preporučuje.
Liprolog preparations should not be mixed with insulins produced by other manufacturers or with animal insulin preparations.
Liprolog se ne smije miješati s inzulinima drugih proizvođača niti s inzulinskim pripravcima životinjskog podrijetla.
Liprolog should be mixed with longer-acting human insulins only on the advice of a doctor.
Liprolog se smije miješati s humanim inzulinima dugog djelovanja samo po preporuci liječnika.
Liprolog should only be used in children in preference to soluble insulin when a fast action of insulin might be beneficial.
Liprolog se umjesto topljivog inzulina smije primjenjivati u djece samo onda kada može biti koristan brži početak djelovanja.
LIPROLOG solution should look clear and colourless.
LIPROLOG otopina mora biti bistra i bezbojna.
LIPROLOG suspensions - cloudy insulins - should look white after mixing.
LIPROLOG suspenzije – mutni inzulini – nakon miješanja trebaju izgledati bijele.
Liprolog takes effect rapidly and has a shorter duration of activity (2 to 5 hours) given subcutaneously as compared with regular insulin.
Nakon supkutane primjene učinak lijeka Liprolog nastupa vrlo brzo i traje kraće (2 do 5 sati) u usporedbi s običnim inzulinom.